Inactive Instrument

News Biocept Inc Nasdaq

Equities

US09072V2043

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Motion for Asset Sale Approved for Biocept, Inc.	Apr. 02	CI
Biocept, Inc.(OTCPK:BIOC.Q) dropped from NASDAQ Composite Index	23-10-24	CI
Biocept, Inc.(NasdaqCM:BIOC) dropped from S&P TMI Index	23-10-19	CI
Biocept : Bankruptcy - Form 8-K	23-10-16	PU
Biocept, Inc. Filed for Bankruptcy	23-10-13	CI
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept's CNSide Assay to Evaluate Patients with Leptomeningeal Metastases	23-09-22	AQ
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases	23-09-21	BU
Biocept, Inc. Announces the Full Enrollment of 40 Subjects with Breast or Non-Small Cell Lung Cancer	23-09-21	CI
Biocept Signs CNSide Licensing Agreement with plus Therapeutics	23-09-11	AQ
Sector Update: Health Care Stocks Slipping Late Friday8 Afternoon	23-09-08	MT
Sector Update: Health Care Stocks Slipping Friday Afternoon	23-09-08	MT
Sector Update: Health Care	23-09-08	MT
Biocept Signs Non-Exclusive Licensing Agreement With Plus Therapeutics on CNSide Tumor Cell Platform	23-09-08	MT
Wall Street Set to Open Flat Friday as Investors Remain Wary of Potential Interest Rate Hike	23-09-08	MT
Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics	23-09-08	BU
Top Premarket Gainers	23-09-08	MT
Plus Therapeutics, Inc. Enters into License Agreement with Biocept for Cerebrospinal Fluid Tumor Cell Enumeration Assay	23-09-08	CI
Biocept to Participate in the H.C. Wainwright Global Investment Conference	23-09-05	BU
Transcript : Biocept, Inc. - Special Call	23-08-30
Biocept to Hold Business Update Conference Call on August 30, 2023	23-08-28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Biocept Inc Nasdaq

Equities

US09072V2043

Summary

Filters